ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), and is thus associated with higher invasiveness, metastasis, and poor prognosis [6].